You are here

Repatha

Supreme Court rules against Amgen bid to revive cholesterol drug patents

Supreme Court rules against Amgen bid to revive cholesterol drug patents

KFGO/Reuters

Flag link:

Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support

Amgen files brief to Supreme Court ahead of oral arguments — with industry amicus support

Endpoints

Flag link:

Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron

Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron

Fierce Pharma

Flag link:

Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case

Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case

Fierce Pharma

Flag link:

Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme

Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme

Fierce Pharma

Flag link:

Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron

Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron

Fierce Pharma

Flag link:

Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead

Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead

Fierce Pharma

Flag link:

Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers

Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers

BioSpace

PCSK9 inhibitors

Flag link:

Amgen receives FDA approval for Repatha to treat pediatric HeFH patients

Amgen receives FDA approval for Repatha to treat pediatric HeFH patients

Pharmaceutical Business Review

Flag link:

Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron

Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron

Fierce Pharma

PCSK9 inhibitors

Flag link:

Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too

Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too

Endpoints

Flag link:

ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha

ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha

Fierce Pharma

Flag link:

ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients

ACC: Amgen's Repatha cuts cholesterol in rarely studied HIV patients

Fierce Pharma

clinical trials

Flag link:

Two Big Drug Flops Show How Health-Care Economics Have Changed

Two Big Drug Flops Show How Health-Care Economics Have Changed

Bloomberg

Flag link:

AHA: Amgen's Repatha tied to greater risk reduction in high-risk heart attack patients

AHA: Amgen's Repatha tied to greater risk reduction in high-risk heart attack patients

Fierce Pharma

PCSK9 inhibitor

Flag link:

Amgen slashes price tag on cholesterol medicine Repatha by 60% for 2020

Amgen slashes price tag on cholesterol medicine Repatha by 60% for 2020

Yahoo/Reuters

Flag link:

MedCo's PCSK9 challenger steals the show at ESC with winning data

MedCo's PCSK9 challenger steals the show at ESC with winning data

Fierce Pharma

Medicines Company

PCSK9 inhibitors

European Society of Cardiology

Flag link:

Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha

Sanofi, Regeneron score win against Amgen patents on PCSK9 med Repatha

Fierce Pharma

PCSK9 inhibitors

Flag link:

Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst

Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst

Fierce Pharma

Medicines Company

PCSK9 inhibitors

Flag link:

German court blocks sale of Sanofi, Regeneron cholesterol drug

German court blocks sale of Sanofi, Regeneron cholesterol drug

Biopharma Dive

Flag link:

Pages